Skip to main content
. 2007 Feb 28;2007:25935. doi: 10.1155/2007/25935

Figure 3.

Figure 3

Oligomers formed by PVL and modified toxins. Oligomers were checked in solution or after recovery from treated human PMNs, 3–8% (w/v) SDS-PAGE and immunoblotting with anti-LukS-PV and anti-LukF-PV affinity-purified rabbit antibodies. Lane 1: LukS-PV + LukF-PV without membranes, lane 2: PMNs only, lane 3: GST∼LukS-PV + GST∼LukF-PV, lanes 4, 5, 6: toxins applied on PMNs membranes and then saponin/glutaraldehyde treated and heated 5 minutes at 100°C as described in materials and methods, lane 4: LukS-PV + GST∼LukF-PV, lane 5: GST∼LukS-PV + LukF-PV, lane 6: GST∼LukS-PV + GST∼LukF-PV.